Researchers at the University of Glasgow have discovered that haemoglobin levels at the lower end of the "normal" range are linked to higher rates of cancer and heart disease. The study suggests that current global diagnostic standards may be failing to identify millions of at-risk individuals who do not meet the strict criteria for anaemia.
The UK Biobank's 500,000-person warning
By analyzing the medical records of nearly half a million participants from the UK Biobank, researchers identified a dangerous correlation between haemoglobin concentrations and long-term health.. According to the University of Glasgow study, both extremely high and extremely low levels of the oxygen-transporting protein were associated with an increased risk of premature death, cancer, and cardiovascular disease.
The most significant finding, however, involves those whose levels sit within the officially recognized normal range. The data indicates that individuals with mild reductions in haemoglobin—even those who would not be diagnosed with anaemia under current rules—face a measurable increase in early mortality compared to those with higher levels. This suggests that the biological "danger zone" is wider than medical textbooks currently acknowledge.
Why 50-year-old WHO thresholds may be obsolete
Lead author Dr. Malek Ahmad argues that the World Health Organization (WHO) guidelines for diagnosing anaemia have remained unchanged for five decades. This stagnation may be creating a diagnostic gap where patients are only identified as ill once their condition becomes severe, missing the window for early, low-cost intervention.
Dr. Ahmad describes this state as "borderline anaemia," which is frequently associated with iron deficiency and increased morbidity. Because these patients often exhibit only vague symptoms—such as paleness, shortness of breath, or fatigue—their condition is easily overlooked by clinicians who rely solely on the outdated WHO cut-off points to trigger treatment.
57,000 annual hospitalizations and the 10p pill
The public health stakes in the United Kingdom are substantial, with over 57,000 hospital admissions annually linked to anaemia. As reported in the study, the NHS has seen a sharp increase in patients admitted for B-vitamin and iron-deficiency anaemia, a trend the Royal College of GPs has called "very concerning," particularly as the cost-of-living crisis limits access to nutritious food.
Despite the high cost of hospitalization, the solution for many is remarkably inexpensive. The University of Glasgow researchers note that iron supplements can cost as little as 10p per pill, and dietary shifts toward lean red meats, fortified cereals, and leafy greens can effectively restore healthy haemoglobin levels. This creates a stark contrast between the low cost of prevention and the high cost of emergency medical care.
The missing link between obesity, stress, and haemoglobin
While the association between borderline low haemoglobin and early death is clear, the University of Glasgow study acknowledges that a direct causal link has not yet been established. This leaves a critical gap in understanding whether low haemoglobin is the driver of disease or a symptom of other underlying systemic issues.
Further research is required to determine how factors such as obesity, chronic stress,medication side effects, and specific dietary deficiencies contribute to these borderline levels. Until these variables are isolated, it remains unclear if treating the haemoglobin level alone is sufficient to reduce the risk of cancer and cardiovascular disease, or if such treatments must be paired with broader lifestyle interventions.
Comments 0